News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Human Genome Sciences, Inc. Anthrax Drug Said to Work in Animals
October 23, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- An experimental Human Genome Sciences Inc drug worked better than a placebo in treating anthrax exposure in animals, U.S. drug reviewers said in a summary released on Friday.
Twitter
LinkedIn
Facebook
Email
Print
Preclinical
MORE ON THIS TOPIC
Drug Development
Is Revolution ‘the next oncology titan’? Truist analysts make the case
May 18, 2026
·
3 min read
·
Heather McKenzie
Deals
Regeneron, Parabilis set out to create new drug class in deal worth up to $2.3B
May 18, 2026
·
2 min read
·
Gabrielle Masson
Cancer
Regeneron misses again as melanoma combo bows to Merck’s Keytruda in Phase 3
May 18, 2026
·
2 min read
·
Tristan Manalac
Drug Development
Genmab drops 2 antibody assets, including another ProfoundBio ADC
May 15, 2026
·
2 min read
·
Gabrielle Masson